Cargando…

Highlights on Novel Technologies for the Detection of Antibodies to Ro60, Ro52, and SS-B

Objective. We aimed to compare a chemiluminescent immunoassay (CIA, QUANTA Flash) on BIO-FLASH with a multiplex flow immunoassay (MFI) on BioPlex 2200 for the detection of antibodies to Ro60, Ro52, and SS-B. Methods. The study included 241 samples, from patients suffering from systemic autoimmune di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Infantino, M., Bentow, C., Seaman, A., Benucci, M., Atzeni, F., Sarzi-Puttini, P., Olivito, B., Meacci, F., Manfredi, M., Mahler, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3860079/ https://www.ncbi.nlm.nih.gov/pubmed/24376466 http://dx.doi.org/10.1155/2013/978202

Ejemplares similares

Serological epitope profile of anti-Ro52–positive patients with systemic autoimmune rheumatic diseases
por: Infantino, Maria, et al.
Publicado: (2015)

Clinical Comparison of QUANTA Flash dsDNA Chemiluminescent Immunoassay with Four Current Assays for the Detection of Anti-dsDNA Autoantibodies
por: Infantino, Maria, et al.
Publicado: (2015)

Analysis of autoantibodies against Ro52/Ro60 in patients with suspected diagnosis of autoimmune systemic disease
por: Salvador, Iñaki, et al.
Publicado: (2012)

Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis
por: Gkoutzourelas, Athanasios, et al.
Publicado: (2018)

Zinc finger domain of Ro60kD autoantigen is essential for binding of Ro52kD and autoantibodies
por: Routsias, JG, et al.
Publicado: (2003)

Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases
por: Robbins, Ailsa, et al.
Publicado: (2019)

Common and Specific Associations of Anti-SSA/Ro60 and Anti-Ro52/TRIM21 Antibodies in Systemic Lupus Erythematosus
por: Menéndez, Aurora, et al.
Publicado: (2013)

Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies
por: Kryštůfková, Olga, et al.
Publicado: (2014)

Sicca syndrome in the same family – the importance of anti-Ro60, anti-Ro52 and anti-La antibody profiling in Sjögren’s syndrome
por: Koszarny, Arkadiusz, et al.
Publicado: (2021)

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis
por: Hudson, Marie, et al.
Publicado: (2012)

A 52-kD protein is a novel component of the SS-A/Ro antigenic particle
Publicado: (1988)

No Correlations Between the Development of Specific IgA and IgM Antibodies Against Anti-TNF Blocking Agents, Disease Activity and Adverse Side Reactions in Patients with Rheumatoid Arthritis
por: Benucci, Maurizio, et al.
Publicado: (2013)

Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody
por: Sclafani, A., et al.
Publicado: (2019)

TRIM21/Ro52 - Roles in Innate Immunity and Autoimmune Disease
por: Jones, Esther L., et al.
Publicado: (2021)

Antidrug antibodies against TNF-blocking agents: correlations between disease activity, hypersensitivity reactions, and different classes of immunoglobulins
por: Benucci, Maurizio, et al.
Publicado: (2015)

Analysis of anti-Ro52 antibodies in sera of healthy subjects
por: Zimmermann, C, et al.
Publicado: (2001)

From ZeRO to HeRO: Saving lives one HeRO at a time
por: Ratcliff, Dr. Charlotte, et al.
Publicado: (2016)

Vicious circle: systemic autoreactivity in Ro52/TRIM21-deficient mice
por: Bolland, Silvia, et al.
Publicado: (2009)

Isolated anti-Ro52 identifies a severe subset of Sjögren’s syndrome patients
por: Lee, Adrian Y. S., et al.
Publicado: (2023)

Roles of Sulfites in Reverse Osmosis (RO) Plants and Adverse Effects in RO Operation
por: Maeda, Yasushi
Publicado: (2022)

Prevalence of antibodies to Ro-52 in a serologically defined population of patients with systemic sclerosis
por: Parker, Jennifer C, et al.
Publicado: (2009)

Determinants of Risk Infection During Therapy with Anti TNF-Alpha Blocking Agents in Rheumatoid Arthritis
por: Benucci, M, et al.
Publicado: (2012)

Cost Effectiveness Analysis of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. A Systematic Review Literature
por: Benucci, Maurizio, et al.
Publicado: (2011)

Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
por: Benucci, Maurizio, et al.
Publicado: (2013)

EOS at RO-03-UPB
por: Carabas, Mihai
Publicado: (2019)

Douglas R.O. Morrison
Publicado: (2001)

Douglas R.O. Morrison
Publicado: (2001)

Douglas R.O. Morrison
Publicado: (2001)

LHCb-Ro Analysis Meeting
Publicado: (2012)

Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis—an exploratory study
por: Hamberg, Viggo, et al.
Publicado: (2023)

Anti-Ro52 Antibodies and Interstitial Lung Disease in Connective Tissue Diseases Excluding Scleroderma
por: Ferreira, João Pedro, et al.
Publicado: (2012)

Autoantigen TRIM21/Ro52 as a Possible Target for Treatment of Systemic Lupus Erythematosus
por: Yoshimi, Ryusuke, et al.
Publicado: (2012)

Autoantibodies against the Immunoglobulin-Binding Region of Ro52 Link its Autoantigenicity with Pathogen Neutralization
por: Burbelo, Peter D., et al.
Publicado: (2018)

TWEAK/Fn14 Activation Participates in Ro52-Mediated Photosensitization in Cutaneous Lupus Erythematosus
por: Liu, Yale, et al.
Publicado: (2017)

Anti-Ro52-positive antisynthetase syndrome (ASS): a case report and review of the literature
por: Zhu, Yuqing, et al.
Publicado: (2022)

Anti-Ro52/TRIM21 serological subsets identify differential clinical and laboratory parameters
por: Lee, Adrian Y. S., et al.
Publicado: (2022)

The Ro/SSA autoantigen as an immunogen. Some anti-Ro/SSA antibody binds IgG
Publicado: (1986)

Refinement of Computational Access to Molecular Physicochemical Properties: From Ro5 to bRo5
por: Rossi Sebastiano, Matteo, et al.
Publicado: (2022)

Retropseudogenes derived from the human Ro/SS-A autoantigen-associated hY RNAs
por: Perreault, Jonathan, et al.
Publicado: (2005)

Clinical Significances of Antibodies to Ro/SS-A Autoantigens and Its Subtypes in Primary Sjogren’s Syndrome
por: Cho, Chul-Soo, et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_llkh73fsuq4dmo22mi16ram6be